What is Metformin-pioglitazone?

Category: Prescription Drugs

Most popular types: Actoplus Met Glizone M Triglynase


Metformin and pioglitazone is a combination of two oral diabetes medicines that help control blood sugar levels. It is for people with type 2 diabetes who do not use daily insulin injections.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 1
Mild 1
None 2

Commonly reported side effects and conditions associated with Metformin-pioglitazone

Side effect Patients Percentage
Fatigue 2
Diarrhea 1
Irregular heartbeat (cardiac arrhythmia) 1


Based on patients currently taking Metformin-pioglitazone

Dosage Patients Percentage
850-15 mg daily 1

Why patients stopped taking Metformin-pioglitazone

Multiple reasons could be selected

Reason Patients Percentage
Side effects too severe 2
Change in health plan coverage 1
Doctor's advice 1
See all 4 patients who've stopped taking Metformin-pioglitazone


Currently taking Metformin-pioglitazone

Duration Patients Percentage
5 - 10 years 1

Stopped taking Metformin-pioglitazone

Duration Patients Percentage
2 - 5 years 2
10 years or more 2
Adherence Evaluations Percentage
Always 3
Usually 0
Sometimes 2
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 2
A little hard to take 1
Not at all hard to take 2
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 0
$50-99 1
$25-49 0
< $25 1
Not specified 2

What people switch to and from

Patients started taking Metformin-pioglitazone after stopping:

Treatment Patients Percentage
Liraglutide (Victoza) 1
Sitagliptin (Januvia) 1

Patients stopped taking Metformin-pioglitazone and switched to:

Treatment Patients Percentage
Empaglifozin (Jardiance) 1
Glimepiride (Amaryl) 1
Metformin-vildagliptin (Galvus Met) 1
Last updated:
There are no evaluations for Metformin-pioglitazone.